Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

1.850 +0.090 (+5.11%)
Official Closing Price Updated: 7:00 PM EDT, Jun 9, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,210,368
Open 1.790
Bid (Size) 1.840 (600)
Ask (Size) 1.870 (5)
Prev. Close 1.760
Today's Range 1.750 - 1.880
52wk Range 1.120 - 4.910
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recent Winners Become Losers For A Day
The large-cap Russell 1,000 fell 0.35% on the day, but more than 2/3 of stocks in the index were actually up on the day, so breadth was quite strong. 
Via Talk Markets
Cathie Wood Trimmed Stake In Microsoft: Here’s What She Bought
Cathie Wood loaded up on shares of PagerDuty and Gingko Bioworks. 
Via Talk Markets

Performance

YTD
+17.09%
+17.09%
1 Month
+37.04%
+37.04%
3 Month
+49.19%
+49.19%
6 Month
+1.65%
+1.65%
1 Year
-40.51%
-40.51%

More News

Read More
What You Missed On Wall Street On Friday, June 2
Via Talk Markets
Cathie Wood Trimmed This Big Tech Stock Holding But Bulked Up On SaaS Provider PagerDuty And Ginkgo Bioworks
Via Benzinga
Why Shares Of Ginkgo Bioworks (DNA) Are Up Today
Via Benzinga
Ginkgo Bioworks Holdings: Q1 Earnings Insights
Via Benzinga
Earnings Preview: Ginkgo Bioworks Holdings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
Via Benzinga
Dell, Broadcom, SentinelOne And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
US Stocks Turn Higher; ISM Manufacturing PMI Drops In May
Via Benzinga
TheStreetReports: AI Biomedical Companies Disrupting Healthcare: INBS, DNA, IBRX, CDIO
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Reasons Why Cathie Wood Is Buying Ginkgo Bioworks Stock Hand Over Fist
Via The Motley Fool
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich … or Broke.
Via InvestorPlace
3 Key Biotech Trends for 2023 And Beyond
Via The Motley Fool
Ginkgo Bioworks Q1 Sales Beat Expectations, But Analyst Downgrades Stock On Guidance Concerns
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
Via Benzinga
Disney, Sonos, Desktop Metal And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
After-Hours Action: Why Ginkgo Bioworks Stock Is Sliding
Via Benzinga
DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates
Via InvestorPlace
Down 76% From Its High, Can Ginkgo Bioworks Stock Turn Things Around?
Via The Motley Fool
7 Best Cathie Wood Stocks for Your May 2023 Buy List
Via InvestorPlace
Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth Stock
Via The Motley Fool
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Via Talk Markets
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Investor Notice: Investigation over Potential Wrongdoing
Via SBWire
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.